GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan · Delayed Price · Currency is TWD 41.55
+0.35 (0.85%)
At close: Mar 5, 2026
GeneFerm Biotechnology Market Cap
GeneFerm Biotechnology has a market cap or net worth of 1.72 billion as of March 5, 2026. Its market cap has decreased by -1.31% in one year.
Market Cap
1.72B
Enterprise Value
1.77B
Revenue
654.88M
Ranking
n/a
PE Ratio
107.18
Stock Price
41.55
Market Cap Chart
Since July 26, 2016, GeneFerm Biotechnology's market cap has decreased from 2.17B to 1.72B, a decrease of -20.76%. That is a compound annual growth rate of -2.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 1.72B | -13.89% |
| Dec 31, 2025 | 2.00B | 2.66% |
| Dec 31, 2024 | 1.95B | -36.91% |
| Dec 29, 2023 | 3.09B | 11.36% |
| Dec 30, 2022 | 2.77B | 53.32% |
| Dec 30, 2021 | 1.81B | 122.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Johnson Chemical Pharmaceutical Works | 2.53B |
| Allied Biotech | 2.49B |
| Golden Biotechnology | 2.30B |
| TSH Biopharm Corporation | 1.99B |
| Tien Liang BioTech | 1.66B |
| InnoPharmax | 1.65B |
| Winston Medical Supply | 1.50B |
| DV Biomed | 1.36B |